Treating dry eye disease: Successful clinical trial

Dry eye disease (DED) affects up to 50% of the U.S. population, costing the nation’s health care system approximately $50 billion annually. A team recently completed a clinical trial using corneal epithelial stem cells to improve outcomes for DED patients.

Share this post:


Recent Posts